Hi @csrwin,
this is a study well worth reading IMO.
The authors acknowledge from the outset that it is a retrospective, descriptive single-center study with the limitations inherent in the absence of clinical controls. On the other hand, these were salvage patients & they provide mortality/ morbidity data & identify deaths unflinchingly where they occurred. This is real-world evidence at its most meaningful, IMO.
Contrast this approach with the devious, calculated & ultimately cynical approach taken by Novartis in the REACH-4 study.
I found this unarguable point to be the single most positive thing to take away from this study:
I don't believe there is ultimately a way for biostatisticians to fail to approve a therapy - even if they don't understand a shred of it - which is safe, & in which overall survival (OS) is higher in responders than in non-responders.
These clinican doctors were clearly significantly impressed by the fact that none of the responders to MSCs died over a median follow-up period of 21 months from first MSCs infusion OS was 90% at 3 months (CI: 79–100), 86%at 6 months (CI:74–100) and 79% at twelve months (CI:65–95)post MSCs infusion.
Cheers,
GLTA(LT)H
- Forums
- ASX - By Stock
- Cell Therapy News/Articles
Hi @csrwin, this is a study well worth reading IMO. The authors...
-
- There are more pages in this discussion • 573 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.47 |
Change
-0.045(2.98%) |
Mkt cap ! $1.672B |
Open | High | Low | Value | Volume |
$1.45 | $1.50 | $1.45 | $8.307M | 5.669M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 151320 | $1.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.47 | 55652 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 150820 | 1.450 |
3 | 79013 | 1.445 |
7 | 113979 | 1.440 |
2 | 54852 | 1.435 |
4 | 159188 | 1.430 |
Price($) | Vol. | No. |
---|---|---|
1.470 | 55652 | 2 |
1.475 | 137352 | 3 |
1.480 | 27852 | 2 |
1.485 | 19000 | 2 |
1.490 | 1000 | 1 |
Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |